{"id":"W2128964123","doi":"10.1093/annonc/mdq027","title":"Results of a phase I/II study of ocrelizumab, a fully humanized anti-CD20 mAb, in patients with relapsed/refractory follicular lymphoma","year":2010,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":144,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Rituximab; Internal medicine; Refractory (planetary science); Follicular lymphoma; Gastroenterology; Neutropenia; Adverse effect; Lymphoma; Cohort; Pharmacokinetics; CD20; Toxicity; Phases of clinical research; Oncology; Surgery","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002671447,0.001264505,0.00233559,0.0003530764,0.0004828242,0.000891475,0.0006183373,0.000958626,0.001407876],"category_scores_gemma":[0.001446771,0.0004742567,0.001585876,0.0003695171,0.001015419,0.000878324,0.0002425099,0.002823407,0.000451148],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008989285,"about_ca_system_score_gemma":0.00107786,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001454915,"about_ca_topic_score_gemma":0.002583091,"domain_scores_codex":[0.9993493,0.0003191653,0.00004214515,0.0000927222,0.00005380811,0.000142743],"domain_scores_gemma":[0.9988068,0.0003372583,0.0001270776,0.0001352303,0.00007538497,0.0005182707],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.6140706,0.0544649,0.02803032,0.0009518718,0.003127247,0.0008499575,0.0007460769,0.004478578,0.07886374,0.0003691325,0.00520854,0.2088391],"study_design_scores_gemma":[0.4223895,0.5116622,0.04812859,0.00005239467,0.002289948,0.0009645299,0.0001782169,0.001483907,0.006632444,0.0003467205,0.005816924,0.00005469319],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9913912,0.00391269,0.0005657685,0.0005753301,0.0001112118,0.0008008681,0.0008752746,0.00005915848,0.001708523],"genre_scores_gemma":[0.9924374,0.001657427,0.001164809,0.000950262,0.0001753585,0.000541239,0.002044198,0.00003534017,0.0009940082],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002671447,"threshold_uncertainty_score":0.01412815,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06645319039979994,"score_gpt":0.4201120801170726,"score_spread":0.3536588897172727,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}